DERAY WILLIAMS: Open Payments
NPI 1073067856 · TALLASSEE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 40 payments from 18 companies in 2025. Trend: 2023 $753 · 2024 $2,535 · 2025 $2,075
Food & beverage: $2,015Education: $60
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $308 |
| AstraZeneca Pharmaceuticals LP | 4 | $237 |
| Gilead Sciences, Inc. | 2 | $233 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $166 |
| ANI Pharmaceuticals, Inc. | 2 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $120 |
| ViiV Healthcare Company | 1 | $118 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $100 |
| Vanda Pharmaceuticals Inc. | 1 | $99 |
| Amgen Inc. | 1 | $99 |
Products named: Kerendia, BREZTRI, Auvelity, PURIFIED CORTROPHIN GEL, XIFAXAN, Yeztugo, Sunosi, FANAPT.
Industry payments across AL — which companies pay providers there.
